Clinical trial
A Precision Medicine Approach to OCD Treatment: Targeting Neuroinflammation
NCT04786548 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Precision Medicine Approach to OCD Treatment: Targeting Neuroinflammation
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 2
- Overall status
- Suspended
- Start date
- April 1, 2021
- Completion date
- August 31, 2026
- Enrollment
- 21 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.